Bregal Sagemount has made a growth investment in LSPedia, a Farmington Hills, Michigan-based provider of compliance and supply chain software for the pharmaceutical industry. The deal backs LSPedia's push to expand its customer base and accelerate a global growth strategy built around serialized product tracking across complex supply chains.

LSPedia, founded in 2013, serves pharmaceutical manufacturers, wholesale distributors, dispensers, healthcare systems, and government agencies. The company helps manage movement and verification of serialized products as regulatory requirements tighten worldwide, making its compliance tools an increasingly necessary part of pharma operations.

The investment reflects Bregal Sagemount's confidence that demand for pharmaceutical supply chain software will keep rising as global serialization mandates take hold. For LSPedia, the capital positions it to scale product innovation and customer reach at a time when drug traceability is no longer optional.